PRIVIGEN
CSL BEHRING CANADA INC
Quick answers
Is there a shortage of PRIVIGEN in Canada?
No. There is no current shortage of PRIVIGEN 10% reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
GAMIMUNE N INJ 5% (IV)
CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD.
GAMIMUNE N 10% (IV)
TALECRIS BIOTHERAPEUTICS INC
WINRHO SDF
APTEVO BIOTHERAPEUTICS LLC
GAMMAGARD S/D
TAKEDA CANADA INC
IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 5%
BAYER CORPORATION
IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 5%
TALECRIS BIOTHERAPEUTICS INC
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02304619
Strength
10%
Dosage Form
Solution
Route
Intravenous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from CSL BEHRING CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
25% · DIN 02274663
5% · DIN 02274655
200MG · DIN 02559773
1500UNIT · DIN 02436078
500UNIT · DIN 02352575
DIN 02410826
DIN 02359251
1250UNIT · DIN 02418746
250UNIT · DIN 02418738
3000UNIT · DIN 02468077
2000UNIT · DIN 02468069
10000000000000GENOME COPIES · DIN 02542560